Forest Laboratories Inc. Class A (FRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

909 THIRD AVENUE NEW YORK, NY 10022

Forest Laboratories, Inc. (Forest) and its subsidiaries develop, manufacture and sell branded forms of ethical drug products. The Company's United States products are marketed directly, or detailed, to physicians by its salesforces. It also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. The Company's products include Lexapro, its SSRI for the treatment of major depression in adults and adolescents and GAD in adults; Namenda, its N-methyl-D-aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension, and Savella an serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia. The Company's United Kingdom and Ireland subsidiaries sell both ethical products and over-the-counter preparations. Their products include Sudocrem, Colomycin, Infacol and Exorex.

Are you looking for this stock instead?

View SEC Filings from FRX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Forest Laboratories Inc. Class A YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding FRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOCHBERG ELAINE SEE REMARKS

  • Officer
 No longer subject to file 2014-07-01 0

COUGHLIN CHRISTOPHER J

  • Director
 No longer subject to file 2014-07-01 0

SALANS LESTER B

  • Director
 No longer subject to file 2014-07-01 0

GOODMAN KENNETH E

  • Director
 No longer subject to file 2014-07-01 0

OLANOFF LAWRENCE S

  • Director
 No longer subject to file 2014-07-01 0

LIEBERMAN GERALD M

  • Director
 No longer subject to file 2014-07-01 0

BASGOZ NESLI

  • Director
 No longer subject to file 2014-07-01 0

ZIMETBAUM PETER J.

  • Director
 No longer subject to file 2014-07-01 0

LYNCH JEROME SVP - SALES

  • Officer
 No longer subject to file 2014-07-01 0

SOLOMON HOWARD

  • Director
 No longer subject to file 2014-07-01 0

FRANCIS PERIER I JR EVP - CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2014-07-01 0

WALSH KEVIN SVP - OPERATIONS

  • Officer
 No longer subject to file 2014-07-01 0

TAGLIETTI MARCO SEE REMARKS

  • Officer
 No longer subject to file 2014-07-01 0

ZIMMERMAN JOSEPH SVP - CHIEF COMPLIANCE OFFICER

  • Officer
 No longer subject to file 2014-07-01 0

MEURY WILLIAM EVP - SALES AND MARKETING

  • Officer
 No longer subject to file 2014-07-01 0

ICAHN CARL C

  • 10% Owner
 No longer subject to file 2014-07-01 0

LEGAULT PIERRE

  • Director
 No longer subject to file 2014-07-01 0

INTRIERI VINCENT J

  • Director
 No longer subject to file 2014-07-01 0

SAUNDERS BRENT L CEO & PRESIDENT

  • Officer
  • Director
 No longer subject to file 2014-06-30 0

KELLY JOHN ALEXANDER SVP - CHIEF COMM'S & IR

  • Officer
 No longer subject to file 2014-06-30 0

BAILEY A ROBERT D SVP CHIEF LEGAL OFF, GC & SEC

  • Officer
 No longer subject to file 2014-06-30 0

LING KAREN SVP - CHIEF HR OFFICER

  • Officer
 No longer subject to file 2014-06-30 0

PAULL SALLY SVP - HUMAN RESOURCES

  • Officer
 25,185 2013-12-09 0

SOLOMON DAVID F SVP-CORPDEV/STRATEGIC PLANNING

  • Officer
 166,858 2013-12-06 0

WEINSTEIN HERSCHEL S SVP GENERAL COUNSEL

  • Officer
 103,509 2013-10-23 0

MURDOLO FRANK J VP - INVESTOR RELATIONS

  • Officer
 33,343 2013-05-21 0

STAFFORD RAYMOND EVP GLOBAL MARKETING

  • Officer
 188,940 2012-05-07 0

GOLDWASSER DAN L

  • Director
 26,932 2011-08-23 0

CANDEE WILLIAM J III

  • Director
 5,953 2010-12-16 0

COHAN GEORGE S

  • Director
 48,658 2010-08-09 0

GERGEL IVAN SR VP - CHIEF SCI. OFFICER

  • Officer
 15,000 2007-12-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments